Mars Acquires Cerba HealthCare's Stake in Cerba Vet and ANTAGENE

Mars, Incorporated Acquires Heska Corporation

April 3, 2023

Medical Devices

Mars, Incorporated agreed to acquire Heska Corporation for $120.00 per share (approximately $1.3 billion equity value), bringing the veterinary diagnostics company into Mars Petcare's Science & Diagnostics business. The acquisition is intended to broaden Mars' point-of-care diagnostic offerings, accelerate R&D and innovation, and expand access to veterinary diagnostics for companion animal health globally.

Gryphon Investors Acquires Vetnique Labs

April 20, 2023

Consumer Products

Gryphon Investors, a San Francisco-based private equity firm, has acquired Vetnique Labs, a Naperville, Illinois-based pet health and wellness company. Gryphon will partner with founder and CEO James Bascharon (who will remain in role and retain a significant stake) to expand Vetnique’s product portfolio and geographic reach; financial terms were not disclosed.

Mars Petcare Acquires Champion Petfoods (ORIJEN & ACANA)

November 1, 2022

Food & Beverage

Mars Petcare (part of Mars, Incorporated) has signed a definitive agreement to acquire Champion Petfoods, the Edmonton-based maker of premium pet food brands ORIJEN and ACANA, from an investor group led by Bedford Capital and the Healthcare of Ontario Pension Plan. The undisclosed-value transaction — which brings Champion's more than 800 employees into the Mars Petcare family — is expected to close in the first half of 2023 and will expand Mars' premium pet nutrition portfolio and global distribution footprint.

Merck Animal Health Acquires Vence

September 22, 2022

Agriculture

Merck Animal Health agreed to acquire Vence, a developer of virtual fencing and livestock management technology, from Vence's founders and shareholders. The acquisition (terms undisclosed) expands Merck Animal Health's animal intelligence and precision livestock management capabilities and was expected to close in the third quarter of 2022.

Nextmune Acquires VetBiotek

December 22, 2023

Veterinary

Nextmune, a global specialty animal-health company, acquired VetBiotek, a developer of veterinary dermatology topical formulations including MicroSilver BG and Ceramide III products. The acquisition expands Nextmune’s dermatology portfolio and aims to improve production, packaging, distribution and access of VetBiotek’s products to veterinary clinics and distributors.

Sebia Acquires ORGENTEC Diagnostika from Water Street Healthcare Partners

June 30, 2021

Medical Devices

Sebia, a France-based provider of clinical protein electrophoresis systems, agreed to acquire ORGENTEC Diagnostika (including subsidiaries Corgenix and AROTEC) from Water Street Healthcare Partners. The acquisition expands Sebia's capabilities and product portfolio in autoimmune and infectious-disease diagnostics, clinical trials support, and global commercial reach.